These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3037284)

  • 1. The role of ribosomes in the sensitivity of mycobacteria to tuberactinomycin.
    Yamada T
    Microbiol Immunol; 1987; 31(2):179-81. PubMed ID: 3037284
    [No Abstract]   [Full Text] [Related]  

  • 2. The translocation inhibitor tuberactinomycin binds to nucleic acids and blocks the in vitro assembly of 50S subunits.
    Yamada T; Teshima T; Shiba T; Nierhaus KH
    Nucleic Acids Res; 1980 Dec; 8(23):5767-77. PubMed ID: 6258151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of [14C]tuberactinomycin O to ribosomes from Mycobacterium smegmatis.
    Yamada T; Teshima T; Shiba T
    J Antibiot (Tokyo); 1985 Feb; 38(2):266-9. PubMed ID: 2987173
    [No Abstract]   [Full Text] [Related]  

  • 4. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
    Yamada T; Mizuguchi Y; Suga K
    J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
    [No Abstract]   [Full Text] [Related]  

  • 5. tRNA binding to programmed ribosomes increases the ribosomal affinity for tuberactinomycin O.
    Yamada T; Teshima T; Shiba T; Nierhaus KH
    FEBS Lett; 1985 Jan; 179(1):37-40. PubMed ID: 2981179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of di-beta-lysyl-capreomycin IIA and palmitoyl tuberactinamine N against drug-resistant mutants with altered ribosomes.
    Yamada T; Teshima T; Shiba T
    Antimicrob Agents Chemother; 1981 Dec; 20(6):834-6. PubMed ID: 6173016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of [14C]tuberactinomycin O, an antibiotic closely related to viomycin, to the bacterial ribosome.
    Misumi M; Tanaka N; Shiba T
    Biochem Biophys Res Commun; 1978 Jun; 82(3):971-6. PubMed ID: 212033
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of viomycin on dihydrostreptomycin binding to bacterial ribosomes.
    Masuda K; Yamada T
    Biochim Biophys Acta; 1976 Jul; 435(4):333-9. PubMed ID: 60132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.
    Akbergenov R; Shcherbakov D; Matt T; Duscha S; Meyer M; Wilson DN; Böttger EC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4712-7. PubMed ID: 21768509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic studies on viomycin and tuberactinomycin (author's transl)].
    Aoyagi T; Kawai T; Yamada Y; Fujino T; Kaneko K
    Kekkaku; 1975 Oct; 50(10):295-301. PubMed ID: 175205
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of ribosomes from viomycin-sensitive and -resistant strains of Mycobacterium smegmatis.
    Yamada T; Masuda K; Shoji K; Hori M
    J Bacteriol; 1972 Oct; 112(1):1-6. PubMed ID: 4342812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical studies on tuberactinomycin. VIII. Isolation of tuberactinamine N, the cyclic peptide moiety of tuberactinomycin N, and conversion of tuberactinomycin N to O.
    Wakamiya T; Shiba T
    J Antibiot (Tokyo); 1975 Apr; 28(4):292-7. PubMed ID: 808523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
    Tsukamura M
    Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of palmitoyltuberactinamine N and di-beta-lysylcapreomycin IIA.
    Yamada T; Yamanouchi T; Ono Y; Nagata A; Wakamiya T; Teshima T; Shiba T
    J Antibiot (Tokyo); 1983 Dec; 36(12):1729-34. PubMed ID: 6198315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
    Tsukamura M; Yamori S
    Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Neurospora VS ribozyme cleavage by tuberactinomycin antibiotics.
    Olive JE; De Abreu DM; Rastogi T; Andersen AA; Mittermaier AK; Beattie TL; Collins RA
    EMBO J; 1995 Jul; 14(13):3247-51. PubMed ID: 7621836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of dihydrostreptomycin to ribosomes from viomycin-sensitive and -resistant strains of Mycobacterium smegmatis.
    Masuda K; Yamada T; Hori M
    Biken J; 1974 Mar; 17(1):33-4. PubMed ID: 4136561
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions between viomycin resistance and streptomycin resistance on ribosomes of Mycobacterium smegmatis.
    Mizuguchi Y; Suga K; Yamada T
    Microbiol Immunol; 1979; 23(7):581-94. PubMed ID: 228160
    [No Abstract]   [Full Text] [Related]  

  • 19. Viomycin resistance: alterations of either ribosomal subunit affect the binding of the antibiotic to the pair subunit and the entire ribosome becomes resistant to the drug.
    Choi EC; Misumi M; Nishimura T; Tanaka N; Nomoto S; Teshima T; Shiba T
    Biochem Biophys Res Commun; 1979 Apr; 87(3):904-10. PubMed ID: 222276
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies in vitro on the antituberculous activities of tuberactinomycin (TUM) and tuberactinomycin-N (TUM-N) (author's transl)].
    Maekawa N; Ikeda N; Oda Y; Uratsuji Y; Inagake H
    Kekkaku; 1977 May; 52(5):211-8. PubMed ID: 407391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.